Join Matindale-Hubbell Connected



Search Results (2767)

  
Documents on biotech life sciences
 

View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLValeant Recalls Children’s Contaminated Respiratory Infection Treatment
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on January 5, 2015
Valeant Pharmaceuticals North America LLC voluntarily recalled one lot of its ribavirin powder for solutions, Virazole, according to a notification from the U.S. Food and Drug Administration.

 

HTMLFDA Believes Herbalife Video is Misleading
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 31, 2014
The Deputy Commissioner for Foods and Veterinary Medicine Michael Taylor of the U.S. Food and Drug Administration admonished Herbalife Ltd. for misleading consumers in a recent YouTube video and asked the company to take the video down.

 

HTMLDangers Affiliated with Cold Medicine
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 31, 2014
As winter settles in, so does the cold and flu season. It is time for many people to get their annual flu shots or go to the pharmacy and pick up a new bottle of cold medicine. However, reading the label is extremely important and is not done carefully enough, especially when it comes to children....

 

HTMLE-Books Negatively Affect Sleep Patterns
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 12, 2015, previously published on December 26, 2014
The number of people using electronic reading devices has dramatically increased in recent years, but now research showed these e-readers may be bad for consumer health.

 

HTMLNinth Circuit Affirms Finding That Hospital’s Acquisition of Medical Group Was Anticompetitive
Robert B. Craig; Taft Stettinius & Hollister LLP;
Legal Alert/Article
March 2, 2015, previously published on February 12, 2015
The Federal Trade Commission maintained its winning streak in health care merger cases after the 9th Circuit affirmed an Idaho district court’s ruling that the acquisition of Idaho’s largest physician group by one of the state’s largest health care systems violated Section 7 of...

 

HTMLBill Introduced in Congress Calls for Private Enforcement of All Food Regulations and Would Weaken Preemption Defenses
Jonathan Berman; Jones Day;
Legal Alert/Article
February 26, 2015, previously published on January 2015
Recent years have seen a surge in private class actions alleging that food labels are misleading or misbranded. The viability of many of these cases, however, has been limited by two important provisions of the Food, Drug, and Cosmetic Act ("FDCA"). Section 310 provides that only the...

 

HTMLSummary of Antares Pharma, Inc. v. Medac Pharma. Inc., 2014-1648
Sughrue Mion PLLC;
Legal Alert/Article
February 17, 2015, previously published on November 17, 2014
Within two years of the USPTO issuing a patent the Applicant may request the Office reissue the patent with enlarged claim scope, provided it is “for the invention disclosed in the original patent.” Antares sought and obtained a reissue of its U.S. Patent 7,776,015 (“the...

 

HTMLProposed Rule Would Allow More Physicians to Participate in Multiple ACOs
Rick L. Hindmand; McDonald Hopkins LLC;
Legal Alert/Article
February 13, 2015, previously published on December 11, 2014
On Dec. 1, 2014, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would revise the Medicare Shared Savings Program (MSSP) regulations relating to accountable care organizations (ACOs). These proposed changes were published in the Dec. 8, 2014 Federal Register and...

 

HTMLNew Patent Eligibility Guidance: USPTO Tones Down the Rhetoric
Jana Nelson, William L. Warren; Sutherland Asbill & Brennan LLP;
Legal Alert/Article
February 6, 2015, previously published on December 18, 2014
On December 15, 2014, the U.S. Patent and Trademark Office issued its long-awaited Interim Guidance on Patent Subject Matter Eligibility (published in the Federal Register on December 16, link here: [(79 Fed. Reg. 74618)]). The Guidance supersedes the guidelines for determining patent eligibility...

 

HTMLPTAB Denies Request to Use Covered Business Method Review for Orange Book-Listed Patents
Jennifer L. Blackburn Ph. D., Leslie T. Grab Ph. D., Tina W. McKeon; Kilpatrick Townsend Stockton LLP;
Legal Alert/Article
February 6, 2015, previously published on January 16, 2015
The Patent Trial and Appeals Board (PTAB) denied the request to review four Orange Book-listed patents owned by Jazz Pharmaceuticals, Inc. under the covered business method (CBM) review procedure. The CBM petitions filed by Amneal Pharmaceuticals, Par Pharmaceutical, and Roxane Laboratories...

 


View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>